Weigh Pros and Cons of Palforzia for Peanut Allergy
October 2020
You’ll hear about Palforzia, the first FDA-approved option for peanut allergy desensitization.
It doesn’t allow patients to freely eat peanut products. But it may minimize an allergic reaction from accidental exposure.
Palforzia is a peanut allergen powder given orally in increasing doses to patients 4 to 17 years old. It’s an alternative to peanut oral immunotherapy already being done by some specialists.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote